var _____WB$wombat$assign$function_____ = function(name) {return (self._wb_wombat && self._wb_wombat.local_init && self._wb_wombat.local_init(name)) || self[name]; };
if (!self.__WB_pmw) { self.__WB_pmw = function(obj) { this.__WB_source = obj; return this; } }
{
  let window = _____WB$wombat$assign$function_____("window");
  let self = _____WB$wombat$assign$function_____("self");
  let document = _____WB$wombat$assign$function_____("document");
  let location = _____WB$wombat$assign$function_____("location");
  let top = _____WB$wombat$assign$function_____("top");
  let parent = _____WB$wombat$assign$function_____("parent");
  let frames = _____WB$wombat$assign$function_____("frames");
  let opener = _____WB$wombat$assign$function_____("opener");

window['wistiajsonp-/embed/medias/zfuf1i1su1.jsonp'] = {"media":{"assets":[{"type":"original","slug":"original","display_name":"Original file","details":{},"width":1920,"height":1080,"size":96524803,"bitrate":5270,"public":true,"status":2,"progress":1.0,"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/6a5c06be4059c06aa440ef7a85944ac8.bin","created_at":1569052485},{"type":"iphone_video","slug":"mp4_h264_327k","display_name":"360p","details":{},"container":"mp4","codec":"h264","width":640,"height":360,"ext":"mp4","size":5989237,"bitrate":327,"public":true,"status":2,"progress":1.0,"metadata":{"max_bitrate":114192,"early_max_bitrate":31686,"average_bitrate":41851},"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/2f905a7945c0b13d8583a8e7c3826babc437e8f6.bin","created_at":1569052485,"segment_duration":3,"opt_vbitrate":1200},{"type":"mp4_video","slug":"mp4_h264_199k","display_name":"224p","details":{},"container":"mp4","codec":"h264","width":400,"height":224,"ext":"mp4","size":3656291,"bitrate":199,"public":true,"status":2,"progress":1.0,"metadata":{"max_bitrate":40330,"early_max_bitrate":21962,"average_bitrate":25549},"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/f088dcf2d1ec2348eca45af64945d108132e4992.bin","created_at":1569052485,"segment_duration":3,"opt_vbitrate":300},{"type":"md_mp4_video","slug":"mp4_h264_352k","display_name":"540p","details":{},"container":"mp4","codec":"h264","width":960,"height":540,"ext":"mp4","size":6455537,"bitrate":352,"public":true,"status":2,"progress":1.0,"metadata":{"max_bitrate":113868,"early_max_bitrate":31170,"average_bitrate":45109},"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/f6dfd7c702c7d3eada815e13c26b4296baee9305.bin","created_at":1569052485,"segment_duration":3,"opt_vbitrate":1800},{"type":"hd_mp4_video","slug":"mp4_h264_437k","display_name":"720p","details":{},"container":"mp4","codec":"h264","width":1280,"height":720,"ext":"mp4","size":8016119,"bitrate":437,"public":true,"status":2,"progress":1.0,"metadata":{"max_bitrate":156996,"average_bitrate":56014,"early_max_bitrate":37805},"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/ae59261e139d6ea432b88112d4fa54a9f9e1ee06.bin","created_at":1569052485,"segment_duration":3,"opt_vbitrate":3750},{"type":"hd_mp4_video","slug":"mp4_h264_683k","display_name":"1080p","details":{},"container":"mp4","codec":"h264","width":1920,"height":1080,"ext":"mp4","size":12526685,"bitrate":683,"public":true,"status":2,"progress":1.0,"metadata":{"max_bitrate":302529,"early_max_bitrate":54895,"average_bitrate":87533},"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/f8ef06a2163c7a5e822c7ffdbcf16cae4715230d.bin","created_at":1569052485,"segment_duration":3,"opt_vbitrate":5625},{"type":"storyboard","slug":"storyboard_2000x2260","display_name":"Storyboard","details":{},"width":2000,"height":2260,"ext":"jpg","size":450082,"bitrate":0,"public":true,"status":2,"progress":1.0,"metadata":{"frame_count":200,"aspect_ratio":1.77778,"frame_height":113,"frame_width":200},"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/139d8284731eb5165410bf7589f9e64d56396c08.bin","created_at":1569052485},{"type":"still_image","slug":"still_image_1920x1080","display_name":"Image","details":{},"width":1920,"height":1080,"size":424222,"bitrate":0,"public":true,"status":2,"progress":1.0,"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/d059b4d9aae1dcfbe956b1bd3f632aad.bin","created_at":1569052734}],"distilleryUrl":"https://web.archive.org/web/20220322110920/https://distillery.wistia.com/x","accountKey":"wistia-production_131047","mediaKey":"wistia-production_45935124","type":"Video","mediaType":"Video","progress":1.0,"status":2,"name":"Predicting the risk of renal allograft loss: What is iBox?","duration":143.08,"hashedId":"zfuf1i1su1","branding":false,"enableCustomerLogo":true,"seoDescription":"a Science Explainers video","preloadPreference":null,"flashPlayerUrl":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/flash/embed_player_v2.0.swf?2017-04-20","showAbout":true,"createdAt":1569052485,"firstEmbedForAccount":false,"firstShareForAccount":false,"keyframeAlign":true,"useMediaDataHostLogic":true,"projectId":3680791,"stats":{"loadCount":15752,"playCount":2017,"uniqueLoadCount":8110,"uniquePlayCount":1643,"averageEngagement":0.71762},"trackingTransmitInterval":20,"integrations":{"google_analytics":true},"captions":[{"language":"eng","text":"Every year, nearly 90 thousand patients undergo a kidney transplant worldwide.\n\nFollowing the first transplantations in the 50’s,\n\nallograft survival improved tremendously with a graft surviving longer and longer.\n\nHowever there has been no improvement in the survival rate over the past 20 years.\n\nAnd today, 20% of patients lose their new kidney within 5 years of transplantation.\n\nThese patients must be put back on dialysis\n\nwhilst they return to the waiting list hoping for a new transplant.\n\nSo we need to extend the survival of transplanted kidneys.\n\nTo achieve this, patient monitoring after transplantation should be improved:\n\nwith an individualized understanding of the graft evolution and a personalized treatment.\n\nAt the Paris Transplant Group,\n\nwe investigated this by learning from historical records of more than 7.000 patients.\n\nFor each patient, we collected more than 50 parameters\n\nincluding histopathological, clinical, and biological data.\n\nAnd among those,\n\nwe identified 8 parameters in our model that are able to accurately predict the graft survival.\n\nWe have computed these parameters into an algorithm named iBox.\n\nFor each transplanted patient,\n\nwe are now able to predict their probability of graft survival at 3, 5 and 7 years ahead.\n\nThe iBox has been tested on an external cohort of 4.000 patients,\n\nand in 3 additional randomized clinical trials.\n\nThe iBox risk prediction score has been proven to be highly reliable for patients:\n\nmale and female, from Europe and the US, from different ethnic and social backgrounds,\n\nfrom different allocation systems, covering distinct clinical scenarios,\n\nand with different treatments.\n\nThe iBox is the most validated score available in transplantation.\n\nThe team at the Paris Transplant Group developed the iBox to guide patient monitoring\n\nand made it adaptable to most clinical scenarios, aiming for longer graft survival.\n\nAlso, for the next generation of clinical trials,\n\nthe iBox could accelerate the development of novel anti-rejection treatments,\n\nhelp researchers design new studies and also constitute a valid and early surrogate endpoint.\n\nThis would accelerate the development of novel anti-rejection treatments.\n\nGet further information about iBox in the publication from Alexandre Loupy and his team."},{"language":"fre","text":"Chaque année, près de 90 000 patients subissent une transplantation rénale dans le monde.\n\nAprès les premières transplantations des années 50,\n\nla survie de l'allogreffe s'est considérablement améliorée avec une survie de plus en plus longue.\n\nCependant, il n'y a pas eu d'amélioration du taux de survie au cours des 20 dernières années.\n\nEt aujourd'hui, 20 % des patients perdent leur nouveau rein dans les 5 années qui suivent la transplantation.\n\nCes patients doivent être remis sous dialyse\n\npendant qu'ils retournent sur la liste d'attente dans l'espoir d'une nouvelle greffe.\n\nDonc nous devons prolonger la survie des reins transplantés.\n\npour y parvenir, le suivi des patients après la transplantation doit être amélioré\n\navec une compréhension individualisée de l'évolution de la greffe et un traitement personnalisé.\n\nAu Paris Transplant Group,\n\nnous étudions cette question en nous appuyant sur les données historiques de plus de 7 000 patients.\n\nPour chaque patient, nous avons recueilli plus de 50 paramètres\n\ny compris les données histopathologiques, cliniques et biologiques.\n\nEt parmi ceux-ci,\n\nnous avons identifié 8 paramètres dans notre modèle qui sont capables de prédire avec précision la survie du greffon.\n\nNous avons calculé ces paramètres dans un algorithme appelé iBox.\n\nPour chaque patient transplanté,\n\nnous sommes maintenant en mesure de prédire la probabilité de survie de leur greffon à 3, 5 et 7 ans.\n\nl’iBox a été testé sur une cohorte externe de 4 000 patients,\n\net dans 3 autres essais cliniques randomisés.\n\nLe score de prédiction du risque iBox s'est avéré très fiable pour les patients :\n\nhommes et femmes, d'Europe et des Etats-Unis, d'origines ethniques et sociales différentes,\n\nde différents systèmes d'allocation, couvrant des scénarios cliniques distincts,\n\net suivant différents traitements.\n\nL'iBox donne le score le plus validé disponible en transplantation.\n\nL'équipe du Paris Transplant Group a développé l'iBox pour guider le suivi des patients\n\net l'a rendu adaptable à la plupart des scénarios cliniques, visant à prolonger la survie du greffon.\n\nAussi, pour la prochaine génération d'essais cliniques,\n\nl'iBox pourrait accélérer le développement de nouveaux traitements anti-rejet,\n\naider les chercheurs à concevoir de nouvelles études et constituer un critère d'évaluation de substitution valide et précoce.\n\nCela accélérerait la mise au point de nouveaux traitements anti-rejet.\n\nPlus d'informations sur l’iBox dans la publication d'Alexandre Loupy et de son équipe."}],"hls_enabled":true,"embed_options":{"volumeControl":"true","fullscreenButton":"true","controlsVisibleOnLoad":"true","playerColor":"ff5525","bpbTime":"false","plugin":{"midrollLink-v1":{"links":[{"name":"annotation_1569052623358_587","time":"137.46","duration":"5","text":"Read the BMJ publication","url":"https://web.archive.org/web/20220322110920/https://www.bmj.com/content/366/bmj.l4923","conversionOpportunityKey":"wistia-production_3899448"}],"on":"true"},"captions-v1":{"language":"","onByDefault":"true","on":"true","async":"false"},"share":{"channels":"embed-facebook-twitter","pageTitle":"What is iBox?","pageUrl":"https://web.archive.org/web/20220322110920/https://umaps.wistia.com/medias/zfuf1i1su1","tweetText":"{video_name} A short introduction to the future of #nephrology and #kidney transplantation by @paristxgroup","overrideUrl":"false","on":"true","conversionOpportunityKey":"wistia-production_3899451"}},"vulcan":true,"branding":"false","showCustomerLogo":"false","unalteredStillImageAsset":{"url":"https://web.archive.org/web/20220322110920/https://embed-ssl.wistia.com/deliveries/d059b4d9aae1dcfbe956b1bd3f632aad.png","width":"1920","height":"1080"},"thumbnailAltText":"What is iBox?","playsinline":true}},"options":{}};
window['wistiajsonp-/embed/medias/zfuf1i1su1.jsonp'] = window['wistiajsonp-/embed/medias/zfuf1i1su1.jsonp'];


}
/*
     FILE ARCHIVED ON 11:09:20 Mar 22, 2022 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 10:40:07 Jan 30, 2023.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
*/
/*
playback timings (ms):
  captures_list: 136.464
  exclusion.robots: 0.078
  exclusion.robots.policy: 0.07
  cdx.remote: 0.066
  esindex: 0.009
  LoadShardBlock: 103.843 (3)
  PetaboxLoader3.datanode: 59.962 (4)
  CDXLines.iter: 21.229 (3)
  load_resource: 440.328
  PetaboxLoader3.resolve: 418.66
*/